135 results
8-K
EX-99.1
MTEM
Molecular Templates Inc
26 May 23
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
5:16pm
EXHIBIT 99.1
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO … Society of Clinical Oncology (“ASCO”) Annual Meeting, taking place June 2-6, 2023 in Chicago, IL. One-on-one meetings may be scheduled directly
8-K
EX-99.1
MTEM
Molecular Templates Inc
15 May 23
Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update
4:49pm
a poster on updated clinical data on MT-6402 (ETB targeting PD-L1), June 3, 2023, at the 2023 American Society for Clinical Oncology (ASCO) Annual
8-K
ijgcj7t0
10 Nov 22
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results
4:30pm
8-K
EX-99.1
r95gxcnp7pqbwc
10 Nov 22
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results
4:30pm
8-K
EX-99.2
yenmhqc4 y1
10 Nov 22
Molecular Templates, Inc. Reports Third Quarter 2022 Financial Results
4:30pm
8-K
EX-99.1
2oqmuw1ae5 8vl82c9
11 Aug 22
Molecular Templates, Inc. Reports Second Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
vivk b3ys0m9a3ulp0
12 May 22
Molecular Templates, Inc. Reports First Quarter 2022 Financial Results
12:00am
8-K
EX-99.1
bpu2k8o
15 Nov 21
Molecular Templates, Inc. Reports Third Quarter 2021 Financial Results
7:30am